Mirum Pharmaceuticals, Inc.
MIRM· Nasdaq
Released Nov 2, 2023, after the close
10-Q filed Nov 2, 2023, 33 days after period end · 0000950170-23-058228
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $47.73M | $18.78M | $5.00M | $0.00 |
| Net Income | -$23.59M | -$35.71M | -$47.11M | -$21.51M |
| EPS Diluted |
Mirum Pharmaceuticals, Inc. · CIK 1759425 · Engraved from SEC EDGAR
| -$0.57 |
| -$1.02 |
| -$1.55 |
| -$0.86 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.